Prostate cancer, Gleason 6. Is active surveillance reasonable for me

TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance (careful monitoring without immediate treatment) is a reasonable and commonly recommended option—but whether it's right for YOU depends on other factors your doctor needs to evaluate.

KEY POINTS:

• Gleason 6 tumors grow slowly and rarely spread, which is why doctors often recommend watching rather than treating immediately
• Active surveillance means regular PSA blood tests, imaging, and sometimes repeat biopsies—not "doing nothing"
• Your age, PSA level, how much cancer was found in your biopsy, and your personal preferences all matter in this decision
• Some men with Gleason 6 never need treatment; others eventually do—your doctor can help predict which path you're likely on
• This is a decision YOU make with your oncologist, not something that happens automatically

NEXT STEP: Ask your oncologist: "Based on my specific situation, am I a good candidate for active surveillance, and what would monitoring look like for me?"

---

[[FULL_ANSWER]]

Understanding Your Gleason 6 Diagnosis and Active Surveillance

What Gleason 6 Means

Your Gleason score describes how abnormal your cancer cells look under a microscope compared to healthy prostate tissue. Gleason 6 is the lowest possible score for cancer that's actually diagnosed—it means your cancer cells look fairly similar to normal cells, which generally indicates slower growth and lower risk of spreading.

Why Active Surveillance Is Discussed for Gleason 6

According to the CancerPatientLab Webinars on NCCN Guidelines, doctors recognize that "somebody who is truly a Gleason 6 doesn't really have to worry about it" in the same way they worry about higher-grade cancers. This is because:

• Gleason 6 cancers grow slowly — they typically don't spread quickly to other parts of your body
• Many men never need treatment — some Gleason 6 cancers remain stable for years or even decades without causing problems
• Overtreatment is a real concern — treating cancer that might never cause harm can lead to side effects (like incontinence or erectile dysfunction) that affect quality of life

What Active Surveillance Actually Means

Active surveillance is NOT "doing nothing." It's structured monitoring that typically includes:

• Regular PSA blood tests — usually every 3-6 months initially, then less frequently if stable
• Periodic imaging — such as MRI or ultrasound to track the cancer's size and location
• Possible repeat biopsies — sometimes doctors repeat the biopsy after 1-2 years to confirm the cancer hasn't changed grade
• Close communication with your doctor — you're watching for any signs the cancer is becoming more aggressive

If monitoring shows the cancer is progressing (PSA rising faster, imaging changes, or biopsy showing higher grade), your doctor can recommend treatment at that point.

Important Factors Your Doctor Will Consider

Active surveillance is reasonable for Gleason 6, but it's not automatic. Your oncologist will evaluate:

1. Your age and life expectancy — younger men might benefit from treatment; older men might reasonably choose surveillance
2. Your PSA level — lower PSA generally suggests lower risk
3. How much cancer was found — the percentage of your biopsy cores involved and the volume of cancer matter
4. Your personal preferences — some men prefer the peace of mind of treatment; others prefer to avoid side effects
5. Your ability to follow up — active surveillance requires commitment to regular monitoring appointments

The Clinical Framework

According to the CancerPatientLab Webinars discussing NCCN Guidelines, the decision between active surveillance and radical prostatectomy (surgery to remove the prostate) for early-stage prostate cancer is "one of the basic choice points" in prostate cancer management. The guidelines recognize that this decision "sure would be nice to know with much higher confidence" because the outcomes can be very different depending on the individual patient's situation.

Questions to Ask Your Oncologist

To determine if active surveillance is right for YOUR specific case:

1. "Based on my PSA level, age, and biopsy findings, am I a good candidate for active surveillance?"
2. "What would my monitoring schedule look like, and how often would I need appointments?"
3. "What signs would prompt us to move from surveillance to treatment?"
4. "What are the pros and cons of active surveillance versus treatment for my specific situation?"
5. "If I choose surveillance now, can I still choose treatment later if things change?"

The Bottom Line

Active surveillance is a well-established, reasonable option for many men with Gleason 6 prostate cancer. However, whether it's the right choice for YOU requires a detailed conversation with your oncologist who knows your complete medical picture—your age, PSA level, biopsy results, overall health, and personal values about treatment versus monitoring.

This is a shared decision between you and your care team, not something that's decided by the cancer grade alone.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.